Atlas Trials

Advaxis, Inc.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Advaxis, Inc.

RecordFirmDate
Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer (NCT03847519)Advaxis, Inc.2019-02-12
A Study of Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus Positive (HPV+), NSCLC Following First-Line Induction Chemotherapy (NCT02531854)Advaxis, Inc.2018-12-01
A Study of ADXS-NEO Expressing Personalized Tumor Antigens (NCT03265080)Advaxis, Inc.2018-03-28
A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal (NCT02399813)Advaxis, Inc.2016-06-02
Study of ADXS11-001 in Participants With High Risk Locally Advanced Cervical Cancer (NCT02853604)Advaxis, Inc.2015-12-15
Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors (NCT02386501)Advaxis, Inc.2015-09-01
ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT02325557)Advaxis, Inc.2015-06-04
A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer (NCT02291055)Advaxis, Inc.2015-04-01
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer (NCT02164461)Advaxis, Inc.2015-03-04
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+ (NCT01116245)Advaxis, Inc.2010-04-01

Track Advaxis, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.